Published : 29 November, 2024
In an ET Healthworld Webinar, Dr. Vipul Sheth, Senior Consultant at Rajiv Gandhi Cancer Institute & Centre (RGCIRC), shared insights on the transformative potential of CAR-T cell therapy in cancer treatment. While still experimental and associated with certain risks, including mortality in clinical trials, CAR-T therapy is making significant strides, offering hope for previously untreatable cancers. Dr. Sheth emphasized the ongoing advancements in research and technology, which are making CAR-T therapy safer, more accessible, and applicable to a broader range of cancers. With continued innovation, CAR-T therapy is poised to revolutionize oncology, offering new hope to patients globally.
As a society, RGCIRC is looking forward to get support from generous people
Read More
It is a fact that there are absolutely no substitutes to replace human bloo...
Read More
Volunteers play an important role in today’s hospitals. They help the hos...
Read MoreRajiv Gandhi Cancer Institute & Research Centre is today counted amongst Asia’s premier exclusive cancer centres that offer unique advantage of cutting edge technology, put to use by renowned super specialists. This potent combination of man and machine ensures world-class cancer care to not only patients from India, but also from the neighboring SAARC countries and others.
D - 18, Sector - 5, Rohini, Delhi - 110085 | +91-11-47022222 OPD Timings: 09:00 am to 05:00 pm (All weekdays except Sunday and Holiday) Emergency Services: 24x7 All weekdays
Mahendra Kumar Jain Marg, Niti Bagh, New Delhi - 110049 | Tel: +91-11-45822222 / 2200 OPD Timings: 09:00 am to 05:00 pm (All Weekdays except Sunday and Holiday) Emergency Services: 24x7 All Weekdays
DONATE